Mirae Asset Global Investments
VRCA icon

Mirae Asset Global Investments’s Verrica Pharmaceuticals VRCA Stock Holding History

Mirae Asset Global Investments’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,796
Closed -$351K – 2656
2023
Q4 		$351K Hold
4,796
– – ﹤0.01% 2134
2023
Q3 		$186K Hold
4,796
– – ﹤0.01% 2322
2023
Q2 		$277K Buy
+4,796
New +$291K ﹤0.01% 2212

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Mirae Asset Global Investments's VRCA Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Verrica Pharmaceuticals (VRCA) in Q1 2024, closing a stake of 4,796 shares — an estimated $351K sold.

Mirae Asset Global Investments first reported a position in VRCA in Q2 2023 and held it in 3 quarters. The position peaked at $351K in Q4 2023. 60 funds tracked by Wall St. Rank hold VRCA as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Verrica Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,796 Verrica Pharmaceuticals shares in Q1 2024, an estimated $351K.
  • Mirae Asset Global Investments first reported a position in Verrica Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Verrica Pharmaceuticals position peaked at $351K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.